Intelligent Bio Solutions Inc., a Delaware corporation, has submitted a request to the U.S. Securities and Exchange Commission (SEC) for the acceleration of the effective date of its Registration Statement on Form S-3, initially filed under File No. 333-278025. The company has requested that the Registration Statement be declared effective at 5:00 P.M. Eastern Time on March 27, 2024. This request was made pursuant to Rule 461 of the Securities Act of 1933, as amended. The communication was officially signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc., a Delaware corporation, has submitted a request to the U.S. Securities and Exchange Commission (SEC) for the acceleration of the effective date of its Registration Statement on Form S-3, initially filed under File No. 333-278025. The company has requested that the Registration Statement be declared effective at 5:00 P.M. Eastern Time on March 27, 2024. This request was made pursuant to Rule 461 of the Securities Act of 1933, as amended. The communication was officially signed by Spiro Sakiris, the Chief Financial Officer of Intelligent Bio Solutions Inc.